Expanding Digital Therapeutics Bold Health’s development of comprehensive digital care programs for gastrointestinal conditions presents opportunities to partner with health plans and self-insured employers seeking scalable, tech-driven solutions to manage chronic digestive diseases efficiently.

Recent Funding Boost With a recent $17 million Series A investment led by Rethink Impact and Samsung Next, Bold has capital to expand its digital health platform, upgrade technology infrastructure, and deepen provider and employer outreach efforts.

Targeting Employers and Payers Bold’s partnership model with self-insured employers and health plans highlights a market opportunity to deliver cost-effective, patient-centric gastrointestinal care solutions that can reduce treatment costs and improve employee well-being.

Innovative Care Approach By integrating medication, behavioral therapy, remote monitoring, and proprietary digital therapeutics, Bold Health offers a compelling value proposition to health organizations seeking to innovate in the chronic condition management space.

Market Differentiation As a digital therapeutics company focused on complex chronic conditions like digestive diseases, Bold Health can differentiate itself by emphasizing its personalized, end-to-end care platform, appealing to payers and providers aiming for improved clinical outcomes and cost savings.